Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Gordon

Showing results (961-970 of 1,032) with videos related to

Pageof 104
Sort By:
BMJ Open|August 13, 2017
Bangladesh Environmental Enteric Dysfunction (BEED) study: protocol for a community-based intervention study to validate non-invasive biomarkers of environmental enteric dysfunctionMustafa Mahfuz, Subhasish Das, Ramendra Nath Mazumder, et al.
Msphere|May 14, 2024
A shared group of bacterial taxa in the duodenal microbiota of undernourished Pakistani children with environmental enteric dysfunctionNajeeha T Iqbal, Robert Y Chen, Nicholas W Griffin, et al.
The Lancet. Oncology|July 15, 2022
Lisocabtagene maraleucel as second-line therapy in adults with relapsed or refractory large B-cell lymphoma who were not intended for haematopoietic stem cell transplantation (PILOT): an open-label, phase 2 studyAlison Sehgal, Daanish Hoda, Peter A Riedell, et al.
Science (New York, N.Y.)|February 26, 2016
Gut bacteria that prevent growth impairments transmitted by microbiota from malnourished childrenLaura V Blanton, Mark R Charbonneau, Tarek Salih, et al.
Blood|November 23, 2013
An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab eraZheng Zhou, Laurie H Sehn, Alfred W Rademaker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2015
Randomized Phase III Trial Comparing ABVD Plus Radiotherapy With the Stanford V Regimen in Patients With Stages I or II Locally Extensive, Bulky Mediastinal Hodgkin Lymphoma: A Subset Analysis of the North American Intergroup E2496 TrialRanjana H Advani, Fangxin Hong, Richard I Fisher, et al.
Science Translational Medicine|October 28, 2011
The impact of a consortium of fermented milk strains on the gut microbiome of gnotobiotic mice and monozygotic twinsNathan P McNulty, Tanya Yatsunenko, Ansel Hsiao, et al.
Cell|November 12, 2019
Long-Term Culture Captures Injury-Repair Cycles of Colonic Stem CellsYi Wang, I-Ling Chiang, Takahiro E Ohara, et al.
Science Immunology|May 17, 2024
TREM2 deficiency reprograms intestinal macrophages and microbiota to enhance anti-PD-1 tumor immunotherapyBlanda Di Luccia, Martina Molgora, Darya Khantakova, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 21, 2023
Inducible CRISPR-targeted "knockdown" of human gut <i>Bacteroides</i> in gnotobiotic mice discloses glycan utilization strategiesZachary W Beller, Darryl A Wesener, Timothy R Seebeck, et al.
Pageof 104

Showing results (961-970 of 1,032) with videos related to

Sort By:
Pageof 104
BMJ Open|August 13, 2017
Bangladesh Environmental Enteric Dysfunction (BEED) study: protocol for a community-based intervention study to validate non-invasive biomarkers of environmental enteric dysfunctionMustafa Mahfuz, Subhasish Das, Ramendra Nath Mazumder, et al.
Msphere|May 14, 2024
A shared group of bacterial taxa in the duodenal microbiota of undernourished Pakistani children with environmental enteric dysfunctionNajeeha T Iqbal, Robert Y Chen, Nicholas W Griffin, et al.
The Lancet. Oncology|July 15, 2022
Lisocabtagene maraleucel as second-line therapy in adults with relapsed or refractory large B-cell lymphoma who were not intended for haematopoietic stem cell transplantation (PILOT): an open-label, phase 2 studyAlison Sehgal, Daanish Hoda, Peter A Riedell, et al.
Science (New York, N.Y.)|February 26, 2016
Gut bacteria that prevent growth impairments transmitted by microbiota from malnourished childrenLaura V Blanton, Mark R Charbonneau, Tarek Salih, et al.
Blood|November 23, 2013
An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab eraZheng Zhou, Laurie H Sehn, Alfred W Rademaker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2015
Randomized Phase III Trial Comparing ABVD Plus Radiotherapy With the Stanford V Regimen in Patients With Stages I or II Locally Extensive, Bulky Mediastinal Hodgkin Lymphoma: A Subset Analysis of the North American Intergroup E2496 TrialRanjana H Advani, Fangxin Hong, Richard I Fisher, et al.
Science Translational Medicine|October 28, 2011
The impact of a consortium of fermented milk strains on the gut microbiome of gnotobiotic mice and monozygotic twinsNathan P McNulty, Tanya Yatsunenko, Ansel Hsiao, et al.
Cell|November 12, 2019
Long-Term Culture Captures Injury-Repair Cycles of Colonic Stem CellsYi Wang, I-Ling Chiang, Takahiro E Ohara, et al.
Science Immunology|May 17, 2024
TREM2 deficiency reprograms intestinal macrophages and microbiota to enhance anti-PD-1 tumor immunotherapyBlanda Di Luccia, Martina Molgora, Darya Khantakova, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 21, 2023
Inducible CRISPR-targeted "knockdown" of human gut <i>Bacteroides</i> in gnotobiotic mice discloses glycan utilization strategiesZachary W Beller, Darryl A Wesener, Timothy R Seebeck, et al.
Pageof 104